FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancerAugust 14, 2023Genitourinary Cancer
How useful are circulating tumor cells for early diagnosis?August 9, 2023Breast CancerLung CancerGenitourinary Cancer
Short bursts of activity may cut cancer riskJuly 31, 2023Preventive CareLung CancerRenal Cell CarcinomaGenitourinary CancerGastrointestinal Cancer
No benefit to adding limited radiation in advanced cancerJuly 11, 2023Lung CancerMelanomaRenal Cell CarcinomaGenitourinary CancerHead & Neck/Thyroid Cancers
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Diversity in MedicinePatient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
FDA approves talazoparib for metastatic prostate cancerJune 23, 2023Genitourinary CancerPatient & Survivor CarePractice Management
Huge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
DEI training gives oncology fellows more confidenceJune 22, 2023Diversity in MedicinePractice ManagementRenal Cell CarcinomaSarcoma & GISTCNS/Brain CancerDLBCLFollicular Lymphoma
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CarePractice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncologyJune 15, 2023Mixed TopicsBreast CancerPatient & Survivor CareMetastatic Breast CancerMelanomaRare DiseasesRenal Cell Carcinoma
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CarePractice ManagementLung CancerBreast CancerGenitourinary CancerNonmelanoma Skin CancerMetastatic Breast Cancer
